RealFeedApp beta
- CDC set aside $1.6 million for controversial vaccine trial
The CDC plans to allocate $1.6 million for a trial exposing newborns in Guinea-Bissau to hepatitis B, a risk that experts condemn as unethical and potentially life-threatening.
- Field
- medicine and diagnostics
- What they did
- The Centers for Disease Control and Prevention (CDC) plans to allocate $1.6 million to fund a vaccine trial for hepatitis B that was suspended in January due to ethical concerns.
- Why it matters
- This could be useful for combating hepatitis B, but it has caused outrage among experts because the trial involves exposing newborns in Guinea-Bissau to the virus, creating a high risk of lifelong infection and death.
#cdc#vaccine trial#guinea-bissau#hepatitis b#ethics
